-
Many welcome what they say is greater control over what they eat. “I don’t care about the bread as much. I still eat what I enjoy,” says one Tampa area woman who lost more than 200 pounds taking Mounjaro.
-
New research finds that limiting eating from noon to 8 p.m. helped patients manage weight and blood sugar as much as calorie counting – and was easier to keep up.
-
The medication is called tirzepatide. It is under review to treat obesity in the U.S. A decision is expected later this year.
-
Whether we choose to acknowledge it, obesity is a huge problem in the U.S. This is especially true with kids. Two Jacksonville surgeons who deal with the issue daily answer questions about the problem.
-
Doctors and patients around the country say getting on the high-demand, injectable drugs requires persistence and a fair amount of luck.
-
The drugs can slow digestion so much that it puts patients at increased risk for pulmonary aspiration, which can cause dangerous lung damage, infections and even death, says one anesthesiologist.
-
Interest drops if users potentially have to deal with weekly injections, lack of insurance coverage or a need to continue the medications indefinitely to avoid regaining weight.
-
The autopsy report shows she had a small bowel obstruction caused by scar tissue that formed in her intestine. It's a known but rare risk of bariatric surgeries.
-
New research shows high-dose oral versions of the medication in the blockbuster drugs Ozepmic and Wegovy may work as well as the popular injections — even in hard-to-treat people with diabetes.
-
A small but growing group of young teens are turning to drastic treatments to lose large amounts of weight, things like body-altering surgery and new drugs that rewire metabolism.